Severe hidradenitis suppurativa responding to treatment with secukinumab: a case report.

Br J Dermatol 2018 Jul 25;179(1):182-185. Epub 2018 Mar 25.

Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.

An inappropriate immunological response to an unknown antigen has been suggested to play a role in the pathogenesis of hidradenitis suppurativa (HS). Studies have identified elevated levels of several proinflammatory cytokines, including interleukin (IL)-17A and tumour necrosis factor-α, nominating these as possible therapeutic targets. Secukinumab is an IL-17A monoclonal antibody, which binds to IL-17A and inhibits the cytokine interaction with the IL-17 receptors, inhibiting the inflammatory cascade. Here we report a case of a 47-year-old man, with Hurley stage III lesions on the neck, axillae, breasts, genital skin and buttocks, who had experienced only temporary benefit from different medical treatments over several years. After 12 weeks of treatment with secukinumab, the number of lesions reported by the patient within the period of the last 4 weeks was reduced from 23 to seven, his pain visual analogue scale (VAS) score was reduced from 5 to 3 and pain/utility/handicap VAS score was reduced from 7 to 4. These results may be taken to imply that IL-17 blockade could provide a possible therapeutic approach in the treatment of HS.

Abstract Video

Hidradenitis suppurativa treated with secukinumab, L. Thorlacius et al


Source: British Journal of Dermatology

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.15769DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
July 2018
194 Reads

Publication Analysis

Top Keywords

hidradenitis suppurativa
8
vas score
8
treatment secukinumab
8
score reduced
8
hurley stage
4
47-year-old man
4
report case
4
case 47-year-old
4
stage iii
4
man hurley
4
iii lesions
4
genital skin
4
skin buttocks
4
breasts genital
4
axillae breasts
4
lesions neck
4
neck axillae
4
cascade report
4
il-17 receptors
4
monoclonal antibody
4

Similar Publications